Skip to content

Newsroom

Order our news

Would you like to be included on our distribution list for our news? We would be happy to provide you with our latest press releases and short news by e-mail. This service is free of charge and may be cancelled at any time.

You can cancel this free service at any time by sending an e-mail to ir(at)fmc-ag.com, or by calling +49 (0) 6172 - 609 2525.

The information you provide will only be used to answer your query. For more information on how we process your Personal Data please read our privacy policy.

newsletter registration

| Press release
Fresenius Medical Care announces encouraging results of CALMAG study on phosphate binder OsvaRen® at the 2010 EDTA congress in Munich
Based on data from its recently completed CALMAG (CALcium acetate MAGnesium carbonate evaluation) study, Fresenius Medical Care is announcing a demonstration of the effectiveness of its combined…
| Press release
Fresenius Medical Care reaches agreement with Bumrungrad International to acquire Asia Renal Care
Fresenius Medical Care AG & Co. KGaA (“the company”), the world’s largest provider of dialysis products and services, today announced its signing of a sales and purchase agreement with Bumrungrad…
| Press release
Fresenius Medical Care Confirms Positive Outlook for 2010 – Shareholders Approve 13th Consecutive Annual Dividend Increase
Fresenius Medical Care’s Chief Executive Officer, Dr. Ben Lipps, continues to see attractive growth opportunities, confirming the company’s positive outlook for the 2010 financial year at the annual…
| Press release
Fresenius Medical Care Reports Strong Start for 2010 and Confirms Outlook for Full Year
2010 1st-Quarter Summary:  Net revenue $2,882 million+13%Operating income (EBIT) $423 million+7%Net income attributable to Fresenius Medical Care AG & Co. KGaA $211 million+7%Earnings per…
| Press release
Erster Netzwerktag von Fresenius Medical Care und der Fachhochschule Würzburg-Schweinfurt – mehr als 20 Professoren tauschen sich mit Werksvertretern aus
Sorry, there is no translation of this page available. Bitte entschuldigen Sie: Es steht leider keine Übersetzung dieser Seite zur Verfügung. 
| Press release
Fresenius Medical Care Responds to Chilean Earthquake Emergency
Fresenius Medical Care Chile is working to maintain operation of its clinic network and continue ensuring lifesaving dialysis treatment for patients in the country’s recently affected earthquake…
| Press release
Bayerischer Qualitätspreis für Fresenius Medical Care in Schweinfurt
Sorry, there is no translation of this page available. Bitte entschuldigen Sie: Es steht leider keine Übersetzung dieser Seite zur Verfügung. 
| Press release
Fresenius Medical Care Publishes Form 20-F for the Fiscal Year 2009
Fresenius Medical Care AG & Co. KGaA (“the Company” or “FMC AG & Co. KGaA”), the world’s largest provider of dialysis products and services, today announced that it has filed the annual report 2009…
| Press release
Fresenius Medical Care Reports Excellent 4th-Quarter and Full-Year 2009 Results; Provides strong outlook for 2010
2009 Full-Year Summary Net revenue $11,247 million+6%Operating income (EBIT) $1,756 million+5%Net income attributable to Fresenius Medical Care AG & Co. KGaA $891 million+9%Earnings per…
| Press release
Fresenius Medical Care Successfully Places Senior Notes in the Amount of €250 million
Fresenius Medical Care AG & Co. KGaA (the “Company” or “Fresenius Medical Care”), the world’s largest provider of dialysis products and services, today announced the pricing of Senior Notes due 2016…
| Press release
Fresenius Medical Care Announces the Offering of €250 million of Senior Notes for Refinancing Purposes
Fresenius Medical Care AG & Co. KGaA (the “Company” or “Fresenius Medical Care”), the world’s largest provider of dialysis products and services, today announced that it intends to sell €250 million…
1 ... 20 21 22
Related content

Do you have any questions? Contact us!

Fresenius Medical Care is the world’s leading provider of dialysis products and services. Find out more about the company’s key facts and innovations.